A pancreatic mass and extreme elevation of CA 19-9: a benign masquerade of cholangiocarcinoma.


Journal

Journal of surgical case reports
ISSN: 2042-8812
Titre abrégé: J Surg Case Rep
Pays: England
ID NLM: 101560169

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 03 01 2022
accepted: 09 01 2022
entrez: 21 2 2022
pubmed: 22 2 2022
medline: 22 2 2022
Statut: epublish

Résumé

Carbohydrate antigen 19-9 (CA 19-9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseudotumours. An 83-year-old woman presented with severe obstructive jaundice, weight loss and an extreme elevation of CA 19-9 level of 3295 kU/L. Magnetic resonance cholangiopancreatography (MRCP) revealed a pancreatic mass amputating the biliary tree. Liver function tests revealed a cholestatic pattern and severe hyperbilirubinaemia (289umol/L). IgG4 level was found to be high at 7.97 g/L. After treatment with high-dose corticosteroids, repeat MRCP 2 months later revealed disappearance of the pancreatic mass. There was also normalization of the bilirubin and a dramatic decrease of CA 19-9. This case reports the highest published benign elevation of Ca19.9 level in the setting of IgG4 disease. Differentiation between cholangiocarcinoma and IgG4-RD is important, as the treatment is vastly different.

Identifiants

pubmed: 35186252
doi: 10.1093/jscr/rjac018
pii: rjac018
pmc: PMC8849326
doi:

Types de publication

Case Reports

Langues

eng

Pagination

rjac018

Informations de copyright

Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author(s) 2022.

Références

Mod Rheumatol. 2012 Jun;22(3):414-8
pubmed: 21894525
Br J Surg. 2008 Jun;95(6):727-34
pubmed: 18418862
Am J Gastroenterol. 1990 Apr;85(4):350-5
pubmed: 2183589
HPB (Oxford). 2008;10(2):94-7
pubmed: 18773063
Adv Exp Med Biol. 2015;867:247-60
pubmed: 26530370
J Clin Med Res. 2021 Feb;13(2):75-81
pubmed: 33747321
Pancreatology. 2014 Sep-Oct;14(5):366-72
pubmed: 25278306
Hum Pathol. 2008 Oct;39(10):1548-51
pubmed: 18619645
Am J Gastroenterol. 2013 Apr;108(4):610-7
pubmed: 23318486
HPB (Oxford). 2008;10(2):98-105
pubmed: 18773064
J Am Coll Surg. 2005 Dec;201(6):862-9
pubmed: 16310689
World J Surg. 2004 May;28(5):466-70
pubmed: 15085401
Digestion. 2017;95(2):172-180
pubmed: 28226313
Am J Surg Pathol. 2009 Sep;33(9):1330-40
pubmed: 19718789
Ann Rheum Dis. 2019 Mar;78(3):406-412
pubmed: 30612117

Auteurs

Catherine Hall (C)

Division of Surgery, The Canberra Hospital, Garran, Australia.

Mairi McLaren (M)

Division of Surgery, The Canberra Hospital, Garran, Australia.

Charles Mosse (C)

Division of Surgery, The Canberra Hospital, Garran, Australia.

Classifications MeSH